Form 4: Lemonade CFO Timothy Bixby Executes Stock Option and Sells Shares

Lemonade's CFO, Timothy Bixby, exercised stock options and sold 5,000 shares of common stock on March 24, 2025, according to a recent SEC filing.

Summary

• On March 24, 2025, Timothy Bixby, the CFO of Lemonade, Inc., executed a stock option for 5,000 shares at a price of $23.69.
• Simultaneously, Bixby sold 5,000 shares of Lemonade common stock at $37.5 per share.
• Following these transactions, Bixby directly owns 265,309 shares of Lemonade common stock.
• He also indirectly owns 30,000 shares through the Timothy E Bixby Family Trust.
• The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on August 24, 2024.
• Bixby directly owns 349,300 stock options.

Sentiment

Score: 5

Explanation: This is a routine filing related to insider transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

Insider transactions are common and closely monitored, especially in publicly traded companies like Lemonade. The use of a pre-arranged Rule 10b5-1 trading plan is a standard practice to avoid accusations of trading on inside information.

Comparison to Industry Standards

• It's common for executives at publicly traded companies, such as Lemonade, to have stock option grants as part of their compensation packages.
• Companies like Allstate, Progressive, and Geico also have executives who receive stock options and may periodically exercise and sell shares.
• The use of Rule 10b5-1 trading plans is a standard practice among executives at these and other publicly traded companies to manage their stock transactions and avoid insider trading concerns.

Stakeholder Impact

• The transaction itself is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.
• However, transparency in insider transactions is important for maintaining investor confidence.

Key Dates

Keywords

Lemonade, LMND, Timothy Bixby, CFO, stock options, stock sale, Form 4, insider trading, Rule 10b5-1, beneficial ownership